Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 17-Sep-24
Select bar for recommendation details.
Recommendations | 17-Sep-24 | |
---|---|---|
Buy | 8 | |
Outperform | 15 | |
Hold | 6 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 24 analysts offering 12 month price targets for Intellia Therapeutics Inc have a median target of 66.50, with a high estimate of 144.00 and a low estimate of 24.00. The median estimate represents a 190.01% increase from the last price of 22.93.
High | 528.0% | 144.00 |
Med | 190.0% | 66.50 |
Low | 4.7% | 24.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate | -4.20% |
Average growth rate | -30.55% |
More ▼
Revenue history & estimates in USD
Average growth rate | -43.87% |
Average growth rate | +4.71% |
More ▼